Search for: "Mylan Pharmaceuticals"
Results 121 - 140
of 739
Sort by Relevance
|
Sort by Date
8 Apr 2020, 9:59 pm
Mylan Pharmaceuticals Inc. [read post]
5 Apr 2020, 9:57 pm
Mylan Pharmaceuticals Inc., the Federal Circuit reversed a decision by the U.S. [read post]
17 Mar 2020, 1:32 pm
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan Pharmaceuticals ULC v Eli Lilly… [read post]
9 Jan 2020, 8:25 pm
Mylan Pharmaceuticals Inc. is recalling certain batches of its Nizatidine Capsules, USP, over concerns they may contain a carcinogen. [read post]
13 Nov 2019, 9:15 am
” Similarly, the Board held in Mylan Pharmaceuticals Inc. v. [read post]
22 Oct 2019, 9:15 am
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
27 Sep 2019, 7:20 am
The Securities and Exchange Commission today announced charges against Pennsylvania-based pharmaceutical company Mylan N.V. for accounting and disclosure failures relating to a Department of Justice (DOJ) probe into whether Mylan overcharged Medicaid by…Read the Full Press ReleaseWant to talk to a securities lawyer? [read post]
19 Sep 2019, 9:43 pm
Mylan Pharmaceuticals Inc.; Regents of the University of Minnesota v. [read post]
18 Sep 2019, 6:35 am
District Court in Connecticut alleges Teva, Pfizer, Mylan, and 17 other pharmaceutical companies worked in tandem to create a ‘fair share’ of the generic drug market and avoid price-lowering competition. [read post]
13 Sep 2019, 11:09 am
Mylan Pharmaceuticals Inc., 896 F.3d 1332 (Fed. [read post]
15 Aug 2019, 9:05 pm
District Court for the District of Connecticut against Heritage, Mylan, Teva, and other pharmaceutical manufacturers. [read post]
Inversion Reversion: Deals to Move Corporate HQs Outside U.S. Lose Favor Due to Smaller Tax Benefits
3 Aug 2019, 6:00 am
When Mylan moved its corporate address to the Netherlands in 2015, the pharmaceutical company joined a wave of corporate inversion deals aided by tax advantages of... [read post]
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
18 Jun 2019, 11:31 am
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
16 Jun 2019, 9:30 pm
Mylan Pharmaceuticals Inc.), held that State sovereign immunity does not preclude institution of inter partes review proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d... [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
15 May 2019, 5:27 am
Besides Teva, also Sandoz, Novartis, Mylan and Pfizer are mentioned, among others. [read post]
14 May 2019, 11:24 am
Mylan Labs., Inc., 464 F.3d 1286,1289 (Fed. [read post]
